About Us

Our Labs

Resident Innovators

News & Events

Careers Contact Apply For Residency Login

Careers Contact Apply For Residency Login

About Us Our Labs Resident Innovators Ignite News & Events

News

LabCentral Alum, rare disease biotech Fulcrum Therapeutics sets terms for $77 million IPO

July 9, 2019

Share :

Previous Page Next Page

Back to top

LabCentral is the premier shared lab community for innovative biotech startups. Home to 100 teams and growing fast!

EMAIL SIGN UP

Get the latest updates from the LabCentral blog sent directly to your email by subscribing here.

Your email :

© 2023 LabCentral. All Rights Reserved.

Privacy Policy

501 (C)(3)

Terms Of Service

Resident Portal